Catalent, Inc. to Present at September 2020 Virtual Investor Conferences
September 03 2020 - 8:00AM
Business Wire
Catalent, Inc. (NYSE: CTLT), the leading global provider of
advanced delivery technologies, development, and manufacturing
solutions for drugs, biologics, cell and gene therapies, and
consumer health products, today announced that members of its
executive leadership team will present at two upcoming virtual
investor conferences.
On September 9, 2020 at 10:50 a.m. ET, the Company will present
at the Baird 2020 Global Healthcare Conference. On September 16,
2020 at 11:00 a.m. ET, the Company will present at Morgan Stanley’s
18th Annual Global Healthcare Conference.
A live webcast of both presentations will be accessible through
the Company’s website at http://investor.catalent.com and will be
available for replay following the event.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT) is the leading global provider of
advanced delivery technologies, development, and manufacturing
solutions for drugs, biologics, cell and gene therapies, and
consumer health products. With over 85 years serving the industry,
Catalent has proven expertise in bringing more customer products to
market faster, enhancing product performance and ensuring reliable
clinical and commercial product supply. Catalent employs more than
13,900 people, including approximately 2,400 scientists, at more
than 40 facilities across four continents and in fiscal 2020
generated over $3 billion in annual revenue. Catalent is
headquartered in Somerset, N.J. For more information, please visit
www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200903005134/en/
Investors: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
From Sep 2023 to Sep 2024